Vasopressin in Vasodilatory Shock

被引：20
|
作者：
Ukor, Ida-Fong [1 ]
Walley, Keith R. [1 ]
机构：
[1] Univ British Columbia, Div Crit Care Med, Ctr Heart Lung Innovat, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada
来源：
CRITICAL CARE CLINICS | 2019年 / 35卷 / 02期
基金：
加拿大健康研究院;
关键词：
Vasopressin; Antidiuretic hormone; Vasodilatory shock; Vasoplegia; Sepsis; CENTRAL-NERVOUS-SYSTEM; SENSITIVE K+ CHANNELS; NITRIC-OXIDE SYNTHASE; SEPTIC SHOCK; ARGININE-VASOPRESSIN; HYPERPOLARIZING FACTOR; DOWN-REGULATION; CARDIOVASCULAR-SYSTEM; POTASSIUM CHANNELS; ENDOTHELIAL-CELLS;
D O I：
10.1016/j.ccc.2018.11.004
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
Vasodilatory shock is the final common pathway for all forms of severe shock, with sepsis the most common primary etiology and the leading cause of critical illness related mortality. The pathophysiology of this condition remains incompletely elucidated. Deficiency of the neuropeptide hormone vasopressin seems to play a significant role. The physiology of vasopressin and its interaction with the pathophysiology of vasodilatory shock are described in this review. A brief review of the major randomized controlled trials assessing the efficacy and safety of vasopressin and its analogs in this complex patient cohort is also provided.
引用
收藏
页码：247 / +
页数：16
相关论文
共 50 条
  • [31] Vasopressin in pediatric vasodilatory shock: a multicentred randomized controlled trial
    K Choong
    D Bohn
    D Fraser
    Critical Care, 13 (Suppl 1):
  • [32] Arginine vasopressin in vasodilatory shock: a new therapy approach? Commentary
    Meier-Hellman, A
    ANAESTHESIST, 2002, 51 (08): : 659 - 660
  • [33] Vasopressin: physiology and clinical use in patients with vasodilatory shock: a review
    den Ouden, DT
    Meinders, AE
    NETHERLANDS JOURNAL OF MEDICINE, 2005, 63 (01): : 4 - 13
  • [34] Vasopressin in Pediatric Vasodilatory Shock A Multicenter Randomized Controlled Trial
    Choong, Karen
    Bohn, Desmond
    Fraser, Douglas D.
    Gaboury, Isabelle
    Hutchison, James S.
    Joffes, Ari R.
    Litalien, Catherine
    Menon, Kusum
    McNamara, Patrick
    Ward, Roxanne E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 180 (07) : 632 - 639
  • [35] Systemic and splanchnic haemodynamic effects of vasopressin administration in vasodilatory shock
    Bracco, D
    Chioléro, RL
    Revelly, JP
    INTENSIVE CARE MEDICINE, 2001, 27 : S138 - S138
  • [36] Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock
    Morales, DLS
    Gregg, D
    Helman, DN
    Williams, MR
    Naka, Y
    Landry, DW
    Oz, MC
    ANNALS OF THORACIC SURGERY, 2000, 69 (01): : 102 - 106
  • [37] Vasopressin in vasodilatory shock: hemodynamic stabilization at the cost of the liver and the kidney?
    Bracht, Hendrik
    Asfar, Pierre
    Radermacher, Peter
    Calzia, Enrico
    CRITICAL CARE, 2007, 11 (06):
  • [38] Vasopressin in vasodilatory shock: hemodynamic stabilization at the cost of the liver and the kidney?
    Hendrik Bracht
    Pierre Asfar
    Peter Radermacher
    Enrico Calzia
    Critical Care, 11
  • [39] Vasopressin therapy in dogs with dopamine-resistant hypotension and vasodilatory shock
    Silverstein, Deborah C.
    Waddell, Lori S.
    Drobatz, Kenneth J.
    King, Lesley G.
    JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE, 2007, 17 (04) : 399 - 408
  • [40] Employing vasopressin during cardiopulmonary resuscitation and vasodilatory shock as a lifesaving vasopressor
    Wenzel, V
    Lindner, KH
    CARDIOVASCULAR RESEARCH, 2001, 51 (03) : 529 - 541
12345